QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.130906v1 324/1/244    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lockman, P. R. Articles by Allen, D. D. Search for Related Content PubMed PubMed Citation Articles by Lockman, P. R. Articles by Allen, D. D.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Carrier-Mediated Transport of the Quaternary Ammonium Neuronal Nicotinic Receptor Antagonist N,N'-Dodecylbispicolinium Dibromide at the Blood-Brain Barrier

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas (P.R.L., V.K.M., W.J.G., R.K.M., F.T., D.D.A.); Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky (Z.F.A., P.A.C., L.P.D.); and Department of Pharmaceutical Sciences, Northeastern Ohio Universities College of Pharmacy, Rootstown, Ohio (W.J.G., P.A.C., L.P.D.)

The quaternary ammonium compound N,N'-dodecyl-bispicolinium dibromide (bPiDDB) potently and selectively inhibits nicotinic receptors (nAChRs) mediating nicotine-evoked [³H]dopamine release and decreases nicotine self-administration, suggesting that this polar, charged molecule penetrates the blood-brain barrier (BBB). This report focuses on 1) BBB penetration of bPiDDB; 2) the mechanism of permeation; and 3) comparison of bPiDDB to the cations choline and N-octylnicotinium iodide (NONI), both of which are polar, charged molecules that undergo facilitated BBB transport. The BBB permeation of [³H]choline, [³H]NONI, and [¹⁴C]bPiDDB was evaluated using in situ rat brain perfusion methods. Cerebrovascular permeability surface-area product (PS) values for [³H]choline, [³H]NONI, and [¹⁴C]bPiDDB were comparable (1.33 ± 0.1, 1.64 ± 0.15, and 1.3 ± 0.3 ml/s/g, respectively). To ascertain whether penetration was saturable, unlabeled substrate was added to the perfusion fluid. Unlabeled choline (500 µM) reduced the PS of [³H]choline to 0.15 ± 0.06 µl/s/g (p < 0.01). Likewise, unlabeled bPiDDB (500 µM) reduced the PS of [¹⁴C]bPiDDB to 0.046 ± 0.005 µl/s/g (p < 0.01), whereas unlabeled NONI reduced the PS for [³H]NONI by approximately 50% to 0.73 ± 0.31 µl/s/g. The PS of [¹⁴C]bPiDDB was reduced (p < 0.05) in the presence of 500 µM choline, indicating that the BBB choline transporter may be responsible for the transport of bPiDDB into brain. Saturable kinetic parameters for [¹⁴C]bPiDDB were similar to those for [³H]choline. The current results suggest that bPiDDB uses the BBB choline transporter for 90% of its permeation into brain, and they demonstrate the carrier-mediated BBB penetration of a novel bisquaternary ammonium nAChR antagonist.

Address correspondence to. Dr. Paul R. Lockman, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, 1300 S. Coulter Dr., Amarillo, TX 79106-1712. E-mail: paul.lockman{at}ttuhsc.edu

This article has been cited by other articles:

				Z. A. F. Albayati, L. P. Dwoskin, and P. A. Crooks Pharmacokinetics of the Novel Nicotinic Receptor Antagonist N,N'-Dodecane-1,12-diyl-bis-3-picolinium Dibromide in the Rat Drug Metab. Dispos., October 1, 2008; 36(10): 2024 - 2029. [Abstract] [Full Text] [PDF]